Skip to main content
Erschienen in: Journal of General Internal Medicine 4/2008

01.04.2008 | Original Article

A Mixed Method Study of the Merits of E-Prescribing Drug Alerts in Primary Care

verfasst von: Kate L. Lapane, PhD, Molly E. Waring, MA PhD candidate, Karen L. Schneider, PhD, Catherine Dubé, EdD, Brian J. Quilliam, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The objective of this paper was to describe primary care prescribers’ perspectives on electronic prescribing drug alerts at the point of prescribing.

Design

We used a mixed-method study which included clinician surveys (web-based and paper) and focus groups with prescribers and staff.

Participants

Prescribers (n = 157) working in one of 64 practices using 1 of 6 e-prescribing technologies in 6 US states completed the quantitative survey and 276 prescribers and staff participated in focus groups.

Measurements

The study measures self-reported frequency of overriding of drug alerts; open-ended responses to: “What do you think of the drug alerts your software generates for you?”

Results

More than 40% of prescribers indicated they override drug–drug interactions most of the time or always (range by e-prescribing system, 25% to 50%). Participants indicated that the software and the interaction alerts were beneficial to patient safety and valued seeing drug–drug interactions for medications prescribed by others. However, they noted that alerts are too sensitive and often unnecessary. Participant suggestions included: (1) run drug alerts on an active medication list and (2) allow prescribers to set the threshold for severity of alerts.

Conclusions

Primary care prescribers recognize the patient safety value of drug prescribing alerts embedded within electronic prescribing software. Improvements to increase specificity and reduce alert overload are needed.
Literatur
1.
Zurück zum Zitat Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64.PubMedCrossRef Gandhi TK, Weingart SN, Borus J, et al. Adverse drug events in ambulatory care. N Engl J Med. 2003;348:1556–64.PubMedCrossRef
2.
Zurück zum Zitat Gurwitz JH, Field TS, Harrold L, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16.PubMedCrossRef Gurwitz JH, Field TS, Harrold L, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289:1107–16.PubMedCrossRef
3.
Zurück zum Zitat Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43(12):1171–6.PubMedCrossRef Field TS, Gilman BH, Subramanian S, Fuller JC, Bates DW, Gurwitz JH. The costs associated with adverse drug events among older adults in the ambulatory setting. Med Care. 2005;43(12):1171–6.PubMedCrossRef
4.
Zurück zum Zitat Corley ST. Electronic prescribing: A review of costs and benefits. Top Health Inform Manage. 2003;24(1):29–38. Corley ST. Electronic prescribing: A review of costs and benefits. Top Health Inform Manage. 2003;24(1):29–38.
5.
Zurück zum Zitat van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47.PubMedCrossRef van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47.PubMedCrossRef
6.
Zurück zum Zitat Shah N, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13(1):5–11.PubMedCrossRef Shah N, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc. 2006;13(1):5–11.PubMedCrossRef
7.
Zurück zum Zitat Avery AJ, Savelyich BS, Sheikh A, Morris CJ, Bowler I, Teasdale S. Improving general practice computer systems for patient safety: qualitative study of key stakeholders. Qual Saf Health Care. 2007;16(1):28–33.PubMedCrossRef Avery AJ, Savelyich BS, Sheikh A, Morris CJ, Bowler I, Teasdale S. Improving general practice computer systems for patient safety: qualitative study of key stakeholders. Qual Saf Health Care. 2007;16(1):28–33.PubMedCrossRef
8.
Zurück zum Zitat Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169(6):549–56.PubMed Tamblyn R, Huang A, Perreault R, et al. The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. CMAJ. 2003;169(6):549–56.PubMed
9.
Zurück zum Zitat Agresti A. Categorical data analysis: 2nd edition. New York: Wiley-Interscience; 2002. Agresti A. Categorical data analysis: 2nd edition. New York: Wiley-Interscience; 2002.
10.
Zurück zum Zitat Bell DS, Cretin S, Marken RS, Landman AB. A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities. J Am Med Inform Assoc. 2004;11:60–70.PubMedCrossRef Bell DS, Cretin S, Marken RS, Landman AB. A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities. J Am Med Inform Assoc. 2004;11:60–70.PubMedCrossRef
11.
Zurück zum Zitat Spina J, Glassman PA, Belperio P, Cader R, Asch S. Primary Care Investigative Group of the VA Los Angeles Healthcare System. Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual. 2005;20(1):7–14.PubMedCrossRef Spina J, Glassman PA, Belperio P, Cader R, Asch S. Primary Care Investigative Group of the VA Los Angeles Healthcare System. Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual. 2005;20(1):7–14.PubMedCrossRef
12.
Zurück zum Zitat National Association of Boards of Pharmacy. Information packet: Omnibus Budget Reconciliation counseling and drug use review requirements. Park Ridge, IL, Publ. no. 101-508. 104 Stat 1388, 4401 (February, 1992). National Association of Boards of Pharmacy. Information packet: Omnibus Budget Reconciliation counseling and drug use review requirements. Park Ridge, IL, Publ. no. 101-508. 104 Stat 1388, 4401 (February, 1992).
13.
Zurück zum Zitat Smith DH, Perrin N, Feldstein A, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med. 2006;166(10):1098–104.PubMedCrossRef Smith DH, Perrin N, Feldstein A, et al. The impact of prescribing safety alerts for elderly persons in an electronic medical record: an interrupted time series evaluation. Arch Intern Med. 2006;166(10):1098–104.PubMedCrossRef
14.
Zurück zum Zitat Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003;163(21):2625–31.PubMedCrossRef Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003;163(21):2625–31.PubMedCrossRef
15.
Zurück zum Zitat Foxhall K. E-prescribing goes to Washington. With the federal government behind it, fselectronic prescribing is gaining speed, weight, and more standards. Healthc Inform. 2007;24(6):14–5.PubMed Foxhall K. E-prescribing goes to Washington. With the federal government behind it, fselectronic prescribing is gaining speed, weight, and more standards. Healthc Inform. 2007;24(6):14–5.PubMed
16.
Zurück zum Zitat Tamblyn R, Huang A, Kawasumi Y, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006;13(2):148–59.PubMedCrossRef Tamblyn R, Huang A, Kawasumi Y, et al. The development and evaluation of an integrated electronic prescribing and drug management system for primary care. J Am Med Inform Assoc. 2006;13(2):148–59.PubMedCrossRef
17.
Zurück zum Zitat Bell DS, Friedman MA. E-prescribing and the Medicare Modernization Act of 2003. Health Aff. (Millwood). 2005;24(5):1159–69.CrossRef Bell DS, Friedman MA. E-prescribing and the Medicare Modernization Act of 2003. Health Aff. (Millwood). 2005;24(5):1159–69.CrossRef
Metadaten
Titel
A Mixed Method Study of the Merits of E-Prescribing Drug Alerts in Primary Care
verfasst von
Kate L. Lapane, PhD
Molly E. Waring, MA PhD candidate
Karen L. Schneider, PhD
Catherine Dubé, EdD
Brian J. Quilliam, PhD
Publikationsdatum
01.04.2008
Verlag
Springer-Verlag
Erschienen in
Journal of General Internal Medicine / Ausgabe 4/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0505-4

Weitere Artikel der Ausgabe 4/2008

Journal of General Internal Medicine 4/2008 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.